Details for Patent: 9,433,617
✉ Email this page to a colleague
Which drugs does patent 9,433,617 protect, and when does it expire?
Patent 9,433,617 protects JUXTAPID and is included in one NDA.
This patent has twenty-seven patent family members in eighteen countries.
Summary for Patent: 9,433,617
Title: | Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side-effects |
Abstract: | The present invention provides methods and compositions for treating hyperlipidemia and/or hypercholesterolemia comprising administering to the subject an effective amount of an MTP inhibitor to inhibit hyperlipidemia and/or hypercholesterolemia in said subject, wherein said administration comprises an escalating series of doses of the MTP inhibitor. In some embodiments the method comprises administering at least three step-wise, increasing dosages of the MTP inhibitor to the subject. In some embodiments, the method further comprises the administration of one or more other lipid modifying compounds. |
Inventor(s): | Rader; Daniel J. (Philadelphia, PA) |
Assignee: | The Trustees of the University of Pennsylvania (Philadelphia, PA) |
Application Number: | 15/155,647 |
Patent Claim Types: see list of patent claims | Use; |
Patent landscape, scope, and claims: | More… ↓ |
Drugs Protected by US Patent 9,433,617
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chiesi | JUXTAPID | lomitapide mesylate | CAPSULE;ORAL | 203858-001 | Dec 21, 2012 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | A DOSING REGIMEN FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA AND HYPERLIPIDEMIA IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA USING AT LEAST THREE STEP-WISE INCREASING DOSES | ⤷ Subscribe | ||||
Chiesi | JUXTAPID | lomitapide mesylate | CAPSULE;ORAL | 203858-002 | Dec 21, 2012 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | A DOSING REGIMEN FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA AND HYPERLIPIDEMIA IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA USING AT LEAST THREE STEP-WISE INCREASING DOSES | ⤷ Subscribe | ||||
Chiesi | JUXTAPID | lomitapide mesylate | CAPSULE;ORAL | 203858-003 | Dec 21, 2012 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | A DOSING REGIMEN FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA AND HYPERLIPIDEMIA IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA USING AT LEAST THREE STEP-WISE INCREASING DOSES | ⤷ Subscribe | ||||
Chiesi | JUXTAPID | lomitapide mesylate | CAPSULE;ORAL | 203858-004 | Apr 23, 2015 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | A DOSING REGIMEN FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA AND HYPERLIPIDEMIA IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA USING AT LEAST THREE STEP-WISE INCREASING DOSES | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,433,617
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 1725234 | ⤷ Subscribe | CA 2014 00002 | Denmark | ⤷ Subscribe |
European Patent Office | 1725234 | ⤷ Subscribe | C300634 | Netherlands | ⤷ Subscribe |
European Patent Office | 1725234 | ⤷ Subscribe | PA2014001 | Lithuania | ⤷ Subscribe |
European Patent Office | 1725234 | ⤷ Subscribe | C20140001 00107 | Estonia | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |